NCT02199925View on ClinicalTrials.gov

An Open-Label Study to Evaluate the Efficacy of High-Dose Gammaplex in Children on the Autism Spectrum

PHASE4UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

April 30, 2015

Study Completion Date

July 31, 2015

Conditions
AutismAutistic DisorderAsperger's DisorderPDDPervasive Developmental Disorder
Interventions
DRUG

Gammaplex 5%

Trial Locations (1)

80112

IMMUNOe International Research Centers, Centennial

Sponsors

Collaborators (1)

Bio Products Laboratory
All Listed Sponsors
collaborator

Bio Products Laboratory

OTHER

lead

Isaac Melamed

INDUSTRY